// App-Quantinova.ai

128.0 : Comparative effectiveness of nivolumab (NIVO) relative to standard of care (SOC) for advanced/metastatic (adv/met) gastric or gastroesophageal junction cancer (GC/GEJC): A simulated treatment comparison (STC).

Researchers

Presenter

  • Ian Chau

Principal Investigators

  • Dieter Ayers

  • Sarah Goring

  • Sam Keeping

  • Rebecca Goulding

  • Shannon Cope

  • Eric Chamot

  • Hannah Le

  • Yanqing Xu

  • Pranav Abraham

  • Beata Korytowsky

Medical Centers

  • Royal Marsden Hospital, Surrey, United Kingdom

  • Precision Xtract, Vancouver, BC, Canada

  • Bristol-Myers Sqiubb, Princeton, NJ

Locations

  • United Kingdom

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gastroesophageal junction (GEJ) adenocarcinoma

Biomarkers

  • N/A

Drug/Treatment

  • Nivolumab

Outcome

  • N/A

Study Design

  • Single Arm

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved